Short answer
GE HealthCare (GEHC) filed its Q2 2026 10-Q quarterly report on Jul 29, 2026 for the quarter ended Jun 30, 2026.
GE HealthCare Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Q2 revenue $5.295B, up 5.7% YoY; organic growth 3.5%
- Net income margin 10.6% vs 9.7%; operating margin 14.0% vs 13.1%
- Best segment PDx revenue $843M, up 15.6%; EBIT margin 29.6% vs 29.3%
- Worst segment PCS revenue $675M, down 13.3%; EBIT margin negative 3.8% vs 7.7%
- Tariff refunds $107M received; tariffs reduced operating income $68M and cash flows $63M
Risk Factors
- No material changes to risk factors disclosed in the December 31, 2025 Form 10-K
- No newly added risk factor or triggering event identified
- Regulatory, legal, and compliance risks unchanged from the 2025 Form 10-K
- Operational, competitive, and market risks unchanged from the 2025 Form 10-K
- Financial risks, including liquidity, debt maturities, currency exposure, and concentration, unchanged from the 2025 Form 10-K
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other GE HealthCare quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.